-
Views
-
Cite
Cite
Erratum, Endocrinology, Volume 149, Issue 1, 1 January 2008, Page 366, https://doi.org/10.1210/endo.149.1.9999
Close - Share Icon Share
Extract
In the article “Dihydrotestosterone Differentially Modulates the Mitogen-Activated Protein Kinase and the Phosphoinositide 3-Kinase/Akt Pathways through the Nuclear and Novel Membrane Androgen Receptor in C6 Cells” by Joshua W. Gatson, Paramjit Kaur, and Meharvan Singh (Endocrinology147: 2028–2034), the authors note the following error in their paper. In the legend to Fig. 10, the sentence “The fluorescence histogram, depicting increasing fluorescence intensity on the x-axis and cell number on the y-axis, shows significant labeling of cells with DHT-BSA-FITC” should read “The fluorescence histogram, depicting increasing fluorescence intensity on the x-axis and cell number on the y-axis, shows significant labeling of cells with testosterone-BSA-FITC”. Similarly, the description of the compound within the Methods and Results sections, both pertaining to Fig. 10, should read ‘testosterone-BSA-FITC‘ rather than ‘DHT-BSA-FITC‘. This change does not alter the interpretation of data shown in Fig. 10. The authors apologize for the error.
